| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.43 | 0.005 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |